Chronic Bronchitis

Lung Disease


What is Chronic Bronchitis?

Chronic bronchitis is one of the major conditions contributing to chronic obstructive pulmonary disease (COPD). Bronchitis is a condition in which the air passages of the lungs become inflamed. The inflammation occurs in the trachea (or windpipe), and in the large and small bronchi (or tree-like air passages in the lungs). Bronchitis is the result of irritation or infection, and can either be short-lived (acute) or re-occurring (chronic). When irritation or infection is present in the lungs, the thin mucous linings that protect the lungs become inflamed. As a response to the inflammation, the airway linings start to leak fluids. Coughing is the body’s natural reflex to clear the air passageways in the lung. As a result, sufferers of bronchitis often exhibit a wet, painful cough.

Although dealing with a chronic lung disease, such as bronchitis, can feel overwhelming, remember there’s hope. Here at the Lung Institute, we specialize in using cellular therapy as a treatment for lung disease. If you or a loved one have any other form of lung disease, please contact one of our patient coordinators or call us at (800) 729-3065.

Related Posts

  • chronic_bronchitis_symptoms_and_what_you_can_doAs one of the two primary conditions of COPD, chronic bronchitis can be a significant drain on your quality of life. Causing frequent coughing and the exacerbation of other symptoms, ... Read more
  • Lung GraphicBronchitis is a lung condition that occurs when the bronchial tubes, or air passages, become inflamed as a result of an infection or irritation. When irritation or an infection manifests ... Read more

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.